Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Five FDA-approved drugs may help block COVID-19 virus entry.

A man with HIV developed skin and hair issues after starting HIV treatment, which improved with topical treatment.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Six African American women experienced hair loss after switching to a new HIV medication.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

The AVET system effectively delivers genes to human keratinocytes and may help treat skin diseases.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Eclipta alba leaf alkaloids may help treat HIV by inhibiting the virus's activity.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

Entospletinib effectively prevents eye and skin GVHD in mice.

TMPRSS2 affects COVID-19 severity and treatment options.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.